Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2014-08-25

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1073/pnas.1413216111PMID 25157173PMCID PMC4246978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular basis for dramatic changes in cannabinoid CB1 G protein‐coupled receptor activation upon single and double point mutations

  2013cited by this paper
• Structure of the CCR5 Chemokine Receptor–HIV Entry Inhibitor Maraviroc Complex

  2013influential reference
• Computationally‐predicted CB1 cannabinoid receptor mutants show distinct patterns of salt‐bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding

  2013cited by this paper
• Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants

  2013cited by this paper
• SuperBiHelix method for predicting the pleiotropic ensemble of G-protein–coupled receptor conformations

  2013cited by this paper
• Genetically encoded photo-cross-linkers map the binding site of an allosteric drug on a G protein-coupled receptor.

  2012cited by this paper
• Structure prediction of G protein-coupled receptors and their ensemble of functionally important conformations.

  2012cited by this paper
• Bihelix: Towards de novo structure prediction of an ensemble of G‐protein coupled receptor conformations

  2012cited by this paper
• Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins.

  2011cited by this paper
• Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor

  2011cited by this paper
• Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

  2011cited by this paper
• An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798).

  2011cited by this paper
• Predicted 3D structures for adenosine receptors bound to ligands: comparison to the crystal structure.

  2010cited by this paper
• Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5

  2009cited by this paper
• Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements.

  2008cited by this paper
• Molecular Interactions of CCR5 with Major Classes of Small-Molecule Anti-HIV CCR5 Antagonists

  2008cited by this paper
• Structure of a β1-adrenergic G-protein-coupled receptor

  2008cited by this paper
• The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist

  2008cited by this paper
• High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

  2007cited by this paper
• Structural and Molecular Interactions of CCR5 Inhibitors with CCR5*

  2006cited by this paper
• Predictions of CCR1 Chemokine Receptor Structure and BX 471 Antagonist Binding Followed by Experimental Validation*

  2006cited by this paper
• Porter: a new, accurate server for protein secondary structure prediction

  2005cited by this paper
• Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

  2005cited by this paper
• The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure.

  2004cited by this paper
• Novel Low Molecular Weight Spirodiketopiperazine Derivatives Potently Inhibit R5 HIV-1 Infection through Their Antagonistic Effects on CCR5*

  2001cited by this paper
• The PSIPRED protein structure prediction server

  2000cited by this paper
• A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.

  1999influential reference
• HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

  1996cited by this paper
• Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp

  1996cited by this paper
• DREIDING: A generic force field for molecular simulations

  1990cited by this paper

• Steviol rebaudiosides bind to four different sites of the human sweet taste receptor (T1R2/T1R3) complex explaining confusing experiments

  2024influential citation
• The chemokine receptor CCR5: multi-faceted hook for HIV-1

  2024cites this paper
• Investigating the Effect of GLU283 Protonation State on the Conformational Heterogeneity of CCR5 by Molecular Dynamics Simulations

  2023cites this paper
• Intermediate-state-trapped mutants pinpoint G protein-coupled receptor conformational allostery

  2023cites this paper
• Stimulation of the OR51E2 olfactory receptor promotes prostate cancer cell invasiveness, proliferation and metastasis emergence

  2023cites this paper
• Insight into the Structure and Physicochemical Properties of Potent Chemokine Receptor 5 Inhibitors for the Discovery of Novel Alzheimer's Disease Drugs.

  2023cites this paper
• Development of enhanced conformational sampling methods to probe the activation landscape of GPCRs.

  2022cites this paper
• Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status

  2022cites this paper
• Structures and Agonist Binding Sites of Bitter Taste Receptor TAS2R5 Complexed with Gi Protein and Validated against Experiment.

  2021cites this paper
• Predicted structure of fully activated human bitter taste receptor TAS2R4 complexed with G protein and agonists

  2021cites this paper
• Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT1A Serotonin Receptor Antagonists

  2021cites this paper
• Meet the Editorial Board Member

  2021cites this paper
• Single-molecule imaging reveals distinct effects of ligands on CCR5 dynamics depending on its dimerization status

  2021cites this paper
• Synergic Effects in the Activation of the Sweet Receptor GPCR Heterodimer for Various Sweeteners Predicted Using Molecular Metadynamics Simulations.

  2021cites this paper
• Predicted Structure of Fully Activated Tas1R3/1R3' Homodimer Bound to G Protein and Natural Sugars: Structural Insights into G Protein Activation by a Class C Sweet Taste Homodimer with Natural Sugars.

  2021cites this paper
• Modeling of CCR5 Recognition by HIV-1 gp120: How the Viral Protein Exploits the Conformational Plasticity of the Coreceptor

  2021cites this paper
• Non-full-length Water-Soluble CXCR4QTY and CCR5QTY Chemokine Receptors: Implication for Overlooked Truncated but Functional Membrane Receptors

  2020cites this paper
• Understanding G Protein Selectivity of Muscarinic Acetylcholine Receptors Using Computational Methods

  2019cites this paper
• Modulation of allosteric coupling by mutations: from protein dynamics and packing to altered native ensembles and function

  2018cites this paper
• CCR5 adopts three homodimeric conformations that control cell surface delivery

  2018cites this paper
• CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis.

  2018cites this paper
• Molecular binding mode of PF-232798, a clinical anti-HIV candidate, at chemokine receptor CCR5

  2018cites this paper
• CCR5 structural plasticity shapes HIV-1 phenotypic properties

  2018cites this paper
• DarwinDock and GAG-Dock: Methods and Applications for Small Molecule Docking

  2017influential citation
• PREDICTING GLYCOSAMINOGLYCAN-SURFACE PROTEIN INTERACTIONS: IMPLICATIONS FOR STUDYING AXONAL GROWTH

  2017cites this paper
• Activation mechanism of the G protein-coupled sweet receptor heterodimer with sweeteners and allosteric agonists

  2017influential citation
• The 3D Structure of Human DP Prostaglandin G-Protein-Coupled Receptor Bound to Cyclopentanoindole Antagonist, Predicted Using the DuplexBiHelix Modification of the GEnSeMBLE Method.

  2017cites this paper
• Conformational and Thermodynamic Landscape of GPCR Activation from Theory and Computation.

  2016cites this paper
• Involvement of CCL3/CCR5 Signaling in Dorsal Root Ganglion in Remifentanil-induced Hyperalgesia in Rats

  2016cites this paper
• Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues

  2016cites this paper
• mutLBSgeneDB: mutated ligand binding site gene DataBase

  2016cites this paper
• Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications

  2016cites this paper
• Molecular-Docking-Based Drug Design and Discovery: Rational Drug Design for the Subtype Selective GPCR Ligands

  2016cites this paper
• Short Communication: Limited Anti-HIV-1 Activity of Maraviroc in Mucosal Tissues.

  2016cites this paper
• Predicted Structures for Kappa Opioid G-Protein Coupled Receptor Bound to Selective Agonists

  2015cites this paper
• In vitro and in vivo characterization of the E3 ubiquitin ligase RNF157 in the brain

  2015cites this paper
• Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor

  2015cites this paper
• Molecular level understanding of resistance to nalidixic acid in Salmonella enteric serovar typhimurium associates with the S83F sequence type

  2015cites this paper
• The Predicted Ensemble of Low‐Energy Conformations of Human Somatostatin Receptor Subtype 5 and the Binding of Antagonists

  2015cites this paper
• A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity

  2015cites this paper
• CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells

  2015cites this paper
• Thesis committee members

  2014cites this paper